Harvey Capital Management’s Exact Sciences EXAS Stock Holding History

Harvey Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3,100	Closed	-$269K	–	81
2020 Q2	$269K	Buy	+3,100	New	+$248K	0.13%	62
2017 Q3	–	Sell	-10,000	Closed	-$353K	–	80
2017 Q2	$353K	Hold	10,000	–	–	0.15%	65
2017 Q1	$236K	Hold	10,000	–	–	0.11%	72
2016 Q4	$133K	Hold	10,000	–	–	0.06%	78
2016 Q3	$185K	Hold	10,000	–	–	0.06%	75
2016 Q2	$122K	Hold	10,000	–	–	0.06%	74
2016 Q1	$67K	Sell	10,000 -118,200	-92%	-$756K	0.03%	75
2015 Q4	$1.18M	Sell	128,200 -238,050	-65%	-$2.21M	0.47%	44
2015 Q3	$6.59M	Buy	+366,250	New	+$8.41M	2.63%	15

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Harvey Capital Management's EXAS Position: Q3 2020 in Review

Harvey Capital Management sold out of Exact Sciences (EXAS) in Q3 2020, closing a stake of 3,100 shares — an estimated $269K sold.

Harvey Capital Management first reported a position in EXAS in Q3 2015 and held it in 9 quarters. The position peaked at $6.59M in Q3 2015. 516 funds tracked by Wall St. Rank hold EXAS as of Q3 2020.

Harvey Capital Management reported no remaining Exact Sciences position as of Q3 2020 after selling out during the quarter.
Harvey Capital Management sold 3,100 Exact Sciences shares in Q3 2020, an estimated $269K.
Harvey Capital Management first reported a position in Exact Sciences in Q3 2015 and held it in 9 quarters.
Harvey Capital Management's Exact Sciences position peaked at $6.59M in Q3 2015.
516 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2020.

Based on Harvey Capital Management's 13F filing for Q3 2020, filed 27 Oct 2020.